Cholesterol-rich cell membrane

Cholesterol-rich cell membranes, commonly known as lipid rafts, are dynamic, specialized microdomains within the plasma membrane that are enriched in cholesterol, sphingolipids, and specific proteins (Lingwood & Simons, 2010, Science). These domains act as essential scaffolding platforms that organize signal transduction pathways, facilitate membrane trafficking, and serve as entry points for various pathogens, including viruses like HIV and SARS-CoV-2 (Sviridov et al., 2020, Journal of Lipid Research). In oncology, lipid rafts are often overexpressed or reorganized to promote survival signaling and metastasis, making them attractive targets for synthetic antitumor lipids (Mollinedo & Gajate, 2015, Frontiers in Oncology). Pharmacological intervention typically involves the use of polyene antifungals, such as Amphotericin B, which bind to cholesterol to create lethal pores in the membrane (Gray et al., 2012, PNAS). Other strategies include the use of cyclodextrins to sequester cholesterol or alkylphospholipids that selectively disrupt raft-associated signaling in malignant cells. However, because cholesterol is a fundamental component of all mammalian cell membranes, therapeutic targeting requires high specificity to avoid significant side effects like hemolysis and renal damage.

Other names

Lipid raftCholesterol-rich microdomainDetergent-resistant membraneLiquid-ordered domainMembrane raft

Drugs targeting cholesterol-rich membranes function through several mechanisms: polyene antibiotics bind directly to cholesterol to form trans-membrane pores or surface-active sponges that cause ion leakage and cell death; alkylphospholipids accumulate in these domains to induce apoptosis; and cholesterol-depleting agents disrupt the assembly of signaling complexes by disorganizing the raft structure.